Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications.
Kupffer cell
fibrosis
hepatitis
hepatocellular carcinoma
liver
liver metastasis
liver sinusoidal endothelial cell
nanoformulation
non-parenchymal cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Jul 2023
24 Jul 2023
Historique:
received:
05
05
2023
revised:
21
06
2023
accepted:
21
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Hepatocytes exert pivotal roles in metabolism, protein synthesis and detoxification. Non-parenchymal liver cells (NPCs), largely comprising macrophages, dendritic cells, hepatic stellate cells and liver sinusoidal cells (LSECs), serve to induce immunological tolerance. Therefore, the liver is an important target for therapeutic approaches, in case of both (inflammatory) metabolic diseases and immunological disorders. This review aims to summarize current preclinical nanodrug-based approaches for the treatment of liver disorders. So far, nano-vaccines that aim to induce hepatitis virus-specific immune responses and nanoformulated adjuvants to overcome the default tolerogenic state of liver NPCs for the treatment of chronic hepatitis have been tested. Moreover, liver cancer may be treated using nanodrugs which specifically target and kill tumor cells. Alternatively, nanodrugs may target and reprogram or deplete immunosuppressive cells of the tumor microenvironment, such as tumor-associated macrophages. Here, combination therapies have been demonstrated to yield synergistic effects. In the case of autoimmune hepatitis and other inflammatory liver diseases, anti-inflammatory agents can be encapsulated into nanoparticles to dampen inflammatory processes specifically in the liver. Finally, the tolerance-promoting activity especially of LSECs has been exploited to induce antigen-specific tolerance for the treatment of allergic and autoimmune diseases.
Identifiants
pubmed: 37511628
pii: ijms241411869
doi: 10.3390/ijms241411869
pmc: PMC10380755
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB1066, B15+B17
Références
Molecules. 2022 Feb 04;27(3):
pubmed: 35164326
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):151-166
pubmed: 33128017
World J Gastroenterol. 2021 Apr 28;27(16):1691-1715
pubmed: 33967551
Future Oncol. 2018 Dec;14(28):2957-2967
pubmed: 29712486
Am J Pathol. 1996 Mar;148(3):785-800
pubmed: 8774134
Cancer Lett. 2021 Nov 1;520:222-232
pubmed: 34363903
Cancer Causes Control. 2008 Feb;19(1):33-41
pubmed: 17906958
Cells. 2021 Jul 03;10(7):
pubmed: 34359854
Cells. 2019 Nov 11;8(11):
pubmed: 31718044
Methods Mol Biol. 2023;2669:269-284
pubmed: 37247067
J Control Release. 2022 Oct;350:630-641
pubmed: 36058352
ACS Appl Mater Interfaces. 2018 Dec 5;10(48):41107-41117
pubmed: 30403475
Front Oncol. 2022 Sep 23;12:855794
pubmed: 36212431
J Hepatol. 2022 Apr;76(4):959-974
pubmed: 35120736
Front Physiol. 2021 Oct 11;12:757469
pubmed: 34707514
Front Med (Lausanne). 2021 Jan 08;7:615599
pubmed: 33490096
Pharm Biol. 2013 May;51(5):643-9
pubmed: 23527957
Curr Biol. 2017 Nov 6;27(21):R1147-R1151
pubmed: 29112863
Pharmaceutics. 2022 Aug 02;14(8):
pubmed: 36015237
Gut. 2015 Sep;64(9):1434-43
pubmed: 25500203
Eur J Pharmacol. 2018 Aug 15;833:379-391
pubmed: 29935174
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209703
Hepatology. 2009 Aug;50(2):612-21
pubmed: 19575456
Hepatology. 2008 Dec;48(6):2007-15
pubmed: 19026003
FASEB J. 2005 Dec;19(14):1978-85
pubmed: 16319141
Front Immunol. 2021 May 25;12:637469
pubmed: 34113339
Front Immunol. 2018 Jul 16;9:1591
pubmed: 30061885
Medicine (Baltimore). 2018 Jun;97(24):e11130
pubmed: 29901640
J Cancer. 2019 Oct 6;10(23):5820-5831
pubmed: 31737119
Cells. 2020 Sep 03;9(9):
pubmed: 32899119
Gastroenterology. 2012 Apr;142(4):918-927.e6
pubmed: 22178212
Hepatology. 2023 May 1;77(5):1773-1796
pubmed: 35989535
Int Immunopharmacol. 2023 Feb;115:109601
pubmed: 36571919
Curr Top Med Chem. 2022;22(25):2069-2086
pubmed: 36045528
Semin Immunopathol. 2017 Feb;39(2):153-163
pubmed: 27456849
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428
pubmed: 31028350
Eur J Pharmacol. 2022 Jan 15;915:174512
pubmed: 34555395
Front Microbiol. 2021 Jun 21;12:652962
pubmed: 34234753
Molecules. 2021 Sep 29;26(19):
pubmed: 34641447
Artif Cells Nanomed Biotechnol. 2018 Aug;46(5):1076-1084
pubmed: 28776396
Cell Biol Int. 2010 Dec;34(12):1247-72
pubmed: 21067523
Front Pharmacol. 2022 Apr 04;13:857956
pubmed: 35444532
Hepatology. 2007 Jun;45(6):1454-61
pubmed: 17518370
Nat Commun. 2019 Jul 5;10(1):2993
pubmed: 31278269
Med Res Rev. 2021 Jan;41(1):507-524
pubmed: 33026703
JCI Insight. 2021 Jan 25;6(2):
pubmed: 33332284
ACS Appl Mater Interfaces. 2020 Oct 7;12(40):44407-44419
pubmed: 32865389
Theranostics. 2021 May 8;11(14):6905-6921
pubmed: 34093861
Mol Pharm. 2016 Mar 7;13(3):699-709
pubmed: 26808002
Expert Rev Gastroenterol Hepatol. 2021 Sep;15(9):999-1007
pubmed: 34423721
Exp Dermatol. 2007 Jul;16(7):611-7
pubmed: 17576241
Small. 2015 May 20;11(19):2291-304
pubmed: 25641921
Cell Physiol Biochem. 2015;35(4):1623-32
pubmed: 25824460
Curr Allergy Asthma Rep. 2020 Dec 12;21(1):2
pubmed: 33313967
Adv Mater. 2022 Mar;34(11):e2106456
pubmed: 35029313
J Biomater Appl. 2022 Jul;37(1):151-165
pubmed: 35343281
Cell Rep. 2017 Apr 18;19(3):584-600
pubmed: 28423321
ACS Nano. 2021 Jan 26;15(1):1608-1626
pubmed: 33351586
Drug Des Devel Ther. 2018 Jul 11;12:2149-2161
pubmed: 30034219
Mol Ther Methods Clin Dev. 2016 Dec 24;4:50-61
pubmed: 28344991
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S343-S351
pubmed: 34590138
Adv Healthc Mater. 2015 Dec 30;4(18):2809-15
pubmed: 26627192
Int J Mol Sci. 2015 Dec 29;17(1):
pubmed: 26729094
Indian J Med Microbiol. 2015 Feb;33 Suppl:102-5
pubmed: 25657123
RSC Adv. 2021 Mar 16;11(18):10986-10995
pubmed: 35423573
Med Clin (Barc). 2022 Sep 23;159(6):289-298
pubmed: 35688746
Mol Ther. 2023 Jan 4;31(1):119-133
pubmed: 36146933
Immunology. 2021 Apr;162(4):452-463
pubmed: 33346377
Mol Pharm. 2011 Oct 3;8(5):1899-909
pubmed: 21800888
Int J Nanomedicine. 2021 Dec 08;16:8013-8033
pubmed: 34916792
J Phys Chem C Nanomater Interfaces. 2008;112(43):16809-16817
pubmed: 19194520
Nanomedicine (Lond). 2017 Jun;12(11):1205-1207
pubmed: 28517963
Biochem Pharmacol. 2003 Oct 1;66(7):1307-17
pubmed: 14505810
Hepatology. 2018 Sep;68(3):1070-1086
pubmed: 29572892
Eur J Endocrinol. 2015 Oct;173(4):M33-8
pubmed: 26156970
J Biol Chem. 2000 Apr 28;275(17):12743-51
pubmed: 10777570
ACS Nano. 2010 Jun 22;4(6):3005-14
pubmed: 20518553
Exp Cell Res. 2014 Jun 10;324(2):183-91
pubmed: 24726886
Transl Cancer Res. 2019 Aug;8(4):1466-1475
pubmed: 35116889
Int J Biol Macromol. 2020 Jul 15;155:1420-1431
pubmed: 31734366
J Control Release. 2022 Jul;347:44-54
pubmed: 35483638
Histopathology. 2019 Jul;75(1):63-73
pubmed: 30811632
Cells. 2021 May 06;10(5):
pubmed: 34066322
Cancer Lett. 2020 Feb 1;470:126-133
pubmed: 31730903
Cochrane Database Syst Rev. 2018 Apr 06;4:CD011746
pubmed: 29624208
Mol Cancer. 2017 Aug 30;16(1):149
pubmed: 28854942
J Hepatol. 2018 Feb;68(2):238-250
pubmed: 29154966
Hepatol Res. 2018 Apr;48(5):397-407
pubmed: 29243365
Nat Rev Gastroenterol Hepatol. 2023 Jan;20(1):37-49
pubmed: 36258033
Methods Mol Biol. 2022;2412:145-178
pubmed: 34918245
ACS Nano. 2019 Apr 23;13(4):4410-4423
pubmed: 30883091
Mil Med. 2022 Dec 16;:
pubmed: 36525511
J Nanobiotechnology. 2022 Jan 4;20(1):9
pubmed: 34983554
Surg Oncol. 2013 Mar;22(1):36-47
pubmed: 23253399
Int J Nanomedicine. 2020 Oct 29;15:8383-8400
pubmed: 33149582
Cells. 2020 May 16;9(5):
pubmed: 32429478
Cancers (Basel). 2021 Jun 10;13(12):
pubmed: 34200529
World J Gastroenterol. 2017 Sep 7;23(33):6030-6048
pubmed: 28970719
Biomaterials. 2023 Aug;299:122134
pubmed: 37167895
Chem Biol Drug Des. 2018 May;91(5):996-1006
pubmed: 29288534
ACS Nano. 2014 Aug 26;8(8):8027-39
pubmed: 25093274
Int J Nanomedicine. 2019 May 13;14:3491-3502
pubmed: 31190806
Molecules. 2023 Feb 27;28(5):
pubmed: 36903458
Front Physiol. 2021 Sep 13;12:735573
pubmed: 34588998
ACS Appl Bio Mater. 2021 May 17;4(5):4422-4431
pubmed: 35006854
Biomaterials. 2021 Feb;269:120674
pubmed: 33486345
ACS Nano. 2015 Mar 24;9(3):2405-19
pubmed: 25587629
Hepatology. 2009 Dec;50(6):1904-13
pubmed: 19787806
ACS Infect Dis. 2019 May 10;5(5):659-674
pubmed: 29893548
Hepatology. 1995 May;21(5):1429-37
pubmed: 7737649
ACS Nano. 2018 Aug 28;12(8):8341-8349
pubmed: 30016076
Front Immunol. 2019 Nov 05;10:2525
pubmed: 31787967
Cancer Res. 2018 Sep 1;78(17):4957-4970
pubmed: 29976575
Am J Pathol. 2010 Jan;176(1):14-21
pubmed: 19948827
J Zhejiang Univ Sci B. 2020 Jul;21(7):571-580
pubmed: 32633111
ACS Nano. 2022 Dec 27;16(12):20739-20757
pubmed: 36454190
Nat Rev Dis Primers. 2021 Apr 15;7(1):27
pubmed: 33859205
J Nanobiotechnology. 2021 Oct 30;19(1):355
pubmed: 34717654
Front Immunol. 2021 Aug 31;12:661323
pubmed: 34531850
Int J Pharm. 2019 Apr 20;561:244-264
pubmed: 30851391
J Hepatol. 2020 Nov;73(5):1170-1218
pubmed: 32956768
Anat Sci Int. 2017 Sep;92(4):387-455
pubmed: 28299597
Front Immunol. 2021 Sep 16;12:741305
pubmed: 34603327
Mol Cancer Res. 2007 Jun;5(6):605-14
pubmed: 17579119
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):522-532
pubmed: 35278356
J Immunol. 2009 Feb 15;182(4):1901-11
pubmed: 19201843
Int J Biol Macromol. 2022 May 15;207:402-413
pubmed: 35278509
Physiol Rev. 2021 Jan 1;101(1):147-176
pubmed: 32466724
ACS Nano. 2019 Apr 23;13(4):4778-4794
pubmed: 30964276
Environ Toxicol Pharmacol. 2012 Nov;34(3):1004-13
pubmed: 22986105
Int J Mol Sci. 2021 Aug 08;22(16):
pubmed: 34445235
Am J Physiol Gastrointest Liver Physiol. 2011 Jan;300(1):G71-81
pubmed: 21030611
J Cell Mol Med. 2019 Mar;23(3):1951-1962
pubmed: 30592139
Int J Nanomedicine. 2022 May 20;17:2335-2352
pubmed: 35619893
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G535-42
pubmed: 16269521
J Biomater Appl. 2019 May;33(10):1373-1381
pubmed: 30880566
Clin Mol Hepatol. 2021 Jan;27(1):58-69
pubmed: 33291862
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Adv Mater. 2022 Apr;34(16):e2201095
pubmed: 35218106
Science. 2007 Feb 9;315(5813):820-5
pubmed: 17255476
Curr Pharm Des. 2020;26(4):429-445
pubmed: 31939726
J Hepatol. 2019 Apr;70(4):615-625
pubmed: 30529504
J Clin Transl Hepatol. 2019 Jun 28;7(2):165-171
pubmed: 31293917
iScience. 2021 Oct 25;24(11):103337
pubmed: 34816100
Viruses. 2022 May 07;14(5):
pubmed: 35632728
Semin Ultrasound CT MR. 2016 Dec;37(6):501-510
pubmed: 27986169
Biomaterials. 2012 Jul;33(20):5107-14
pubmed: 22494888
BMC Mol Cell Biol. 2020 Nov 27;21(1):85
pubmed: 33246411
Clin Rev Allergy Immunol. 2008 Feb;34(1):85-102
pubmed: 18270862
Nanomedicine. 2022 Feb;40:102497
pubmed: 34838993
Hepatology. 2022 Jul;76(1):233-250
pubmed: 34990029
Cancer Treat Rev. 2020 Jun;86:102017
pubmed: 32335505
PLoS One. 2013;8(2):e56442
pubmed: 23441194
Int Rev Cell Mol Biol. 2019;349:251-307
pubmed: 31759433
J Hepatol. 2013 Jan;58(1):112-8
pubmed: 22989568
Cold Spring Harb Perspect Med. 2020 Nov 2;10(11):
pubmed: 31964653
Hepatology. 1999 May;29(5):1486-93
pubmed: 10216133
Ann Surg Oncol. 2008 Feb;15(2):590-9
pubmed: 18057991
J Exp Med. 2000 Apr 17;191(8):1269-80
pubmed: 10770795
Front Immunol. 2023 Apr 06;14:1149931
pubmed: 37090718
Mol Biol Rep. 2021 Mar;48(3):2803-2815
pubmed: 33730288
Theranostics. 2019 Feb 12;9(5):1264-1279
pubmed: 30867829
Oncotarget. 2015 Jun 30;6(18):16253-70
pubmed: 25938538
ACS Nano. 2021 May 25;15(5):9111-9125
pubmed: 33988024
Nucleic Acids Res. 2022 May 20;50(9):4840-4859
pubmed: 35524566
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E156-65
pubmed: 25548186
Thorac Surg Clin. 2019 May;29(2):123-131
pubmed: 30927993
J Control Release. 2017 Feb 28;248:10-23
pubmed: 27940184
Pathology. 2019 Oct;51(6):586-592
pubmed: 31445808
Int Immunopharmacol. 2022 Sep;110:108944
pubmed: 35728304
BMC Endocr Disord. 2022 Mar 14;22(1):63
pubmed: 35287643
Anticancer Res. 1995 Mar-Apr;15(2):559-62
pubmed: 7539239
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2830-2837
pubmed: 31298047
J Gastroenterol Hepatol. 2011 Apr;26(4):619-27
pubmed: 21073674
J Hepatol. 2015 Jun;62(6):1349-56
pubmed: 25617499
Histopathology. 2016 Jun;68(7):953-67
pubmed: 26918878
Toxicol Pathol. 1987;15(1):88-92
pubmed: 3576077
Front Immunol. 2021 Sep 07;12:733364
pubmed: 34557195
Colloids Surf B Biointerfaces. 2021 Jan;197:111399
pubmed: 33075660
Front Bioeng Biotechnol. 2022 Apr 06;10:889291
pubmed: 35464732
Front Immunol. 2020 Jan 28;10:3112
pubmed: 32047496
ACS Nano. 2023 Mar 14;17(5):4942-4957
pubmed: 36853930
ACS Omega. 2022 Jun 07;7(24):21325-21336
pubmed: 35755339
J Hepatol. 2018 Jun;68(6):1181-1190
pubmed: 29427729
Cancer Med. 2019 Feb;8(2):773-782
pubmed: 30636370
Front Pharmacol. 2014 Jul 22;5:167
pubmed: 25100997
Liver Int. 2014 Mar;34(3):416-26
pubmed: 23870027
PLoS One. 2012;7(4):e33434
pubmed: 22558072
Cancers (Basel). 2022 Mar 28;14(7):
pubmed: 35406483
Front Oncol. 2022 Aug 05;12:971475
pubmed: 35992879
Front Bioeng Biotechnol. 2022 May 10;10:903424
pubmed: 35620473
J Autoimmun. 2010 Feb;34(1):1-6
pubmed: 19717280
Adv Mater. 2017 Feb;29(7):
pubmed: 27885719
J Biomater Appl. 2017 Aug;32(2):191-205
pubmed: 28610486
Oxid Med Cell Longev. 2020 Dec 24;2020:9374896
pubmed: 33425221
Int J Nanomedicine. 2022 Jun 07;17:2559-2575
pubmed: 35698562
J Nanobiotechnology. 2020 Apr 16;18(1):60
pubmed: 32299505
Acta Biomater. 2022 Oct 1;151:588-599
pubmed: 36002126
Immunother Adv. 2021 May 22;1(1):ltab009
pubmed: 35919740
Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188314
pubmed: 31682895
Mol Cancer Ther. 2008 Mar;7(3):579-89
pubmed: 18347144
Clin Exp Metastasis. 2008;25(3):201-11
pubmed: 18071913
J Control Release. 2021 Aug 10;336:621-634
pubmed: 34246701
J Biomed Nanotechnol. 2021 Jan 1;17(1):18-36
pubmed: 33653494
World J Hepatol. 2022 Jan 27;14(1):1-44
pubmed: 35126838
Clin Exp Metastasis. 2008;25(4):335-44
pubmed: 17891461
Molecules. 2022 Mar 24;27(7):
pubmed: 35408480
ACS Nano. 2022 Sep 27;16(9):14029-14042
pubmed: 36036898
Int J Cancer. 1997 May 16;71(4):612-9
pubmed: 9178816
Exp Biol Med (Maywood). 2020 Jan;245(2):96-108
pubmed: 31924111
Theranostics. 2020 Jan 1;10(3):1281-1295
pubmed: 31938065
Mol Immunol. 2020 Jan;117:201-215
pubmed: 31835202
Pharmacol Ther. 2022 Mar;231:107986
pubmed: 34481812
J Biomed Nanotechnol. 2019 Feb 1;15(2):288-300
pubmed: 30596551
Mol Cancer. 2022 Jan 21;21(1):28
pubmed: 35062949
Nat Nanotechnol. 2016 Oct;11(10):890-899
pubmed: 27479756
Nat Rev Dis Primers. 2021 Sep 9;7(1):65
pubmed: 34504109
Cancer Biol Med. 2023 Jan 12;20(1):
pubmed: 36647777
Int J Mol Sci. 2021 Apr 29;22(9):
pubmed: 33946835
Nanoscale. 2019 Aug 7;11(29):13934-13946
pubmed: 31305839
Sci Adv. 2021 Mar 31;7(14):
pubmed: 33789906
Front Oncol. 2021 Jul 01;11:685706
pubmed: 34277431
Sci Rep. 2017 Mar 09;7:44123
pubmed: 28276530
J Hepatol. 2017 Aug;67(2):370-398
pubmed: 28427875
J Exp Clin Cancer Res. 2007 Dec;26(4):527-33
pubmed: 18365549
J Pharmacol Exp Ther. 2011 Jun;337(3):628-35
pubmed: 21383021
Cancers (Basel). 2021 Nov 22;13(22):
pubmed: 34831021
Mol Aspects Med. 2023 Aug;92:101191
pubmed: 37236017
Nat Rev Dis Primers. 2021 Jan 21;7(1):6
pubmed: 33479224
J Control Release. 2018 Aug 10;283:113-125
pubmed: 29857004
J Cell Physiol. 2022 Jan;237(1):436-449
pubmed: 34514599
Eur J Pharm Biopharm. 2022 Aug;177:175-183
pubmed: 35811038
Antiviral Res. 2020 Oct;182:104925
pubmed: 32866519
Ann Med Surg (Lond). 2015 Sep 03;4(4):331-7
pubmed: 26566435
Mater Today Bio. 2020 May 07;7:100056
pubmed: 32510051
Bioengineered. 2021 Dec;12(2):11124-11135
pubmed: 34923912
Front Immunol. 2022 Aug 01;13:972121
pubmed: 35979360
Eur J Pharm Sci. 2019 Nov 1;139:105036
pubmed: 31446078
J Hepatol. 2014 Sep;61(3):594-9
pubmed: 24798620
Front Immunol. 2021 Jan 08;11:616020
pubmed: 33488627
Adv Drug Deliv Rev. 2020;154-155:79-101
pubmed: 32574575
J Theor Biol. 2018 Feb 14;439:86-99
pubmed: 29203124
Lancet. 2015 Mar 14;385(9972):956-65
pubmed: 25468160
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752
pubmed: 32413340
PLoS One. 2022 Aug 10;17(8):e0272776
pubmed: 35947632
Gastroenterol Rep (Oxf). 2019 Dec 05;8(1):56-65
pubmed: 32104586
Int J Nanomedicine. 2017 May 09;12:3591-3603
pubmed: 28533682
Front Oncol. 2022 Oct 21;12:1042125
pubmed: 36338748
Expert Opin Drug Metab Toxicol. 2019 Mar;15(3):231-244
pubmed: 30677306
Molecules. 2019 Mar 07;24(5):
pubmed: 30866424
Front Immunol. 2019 Jul 31;10:1799
pubmed: 31417566